SCHEMBL9378595

SCHEMBL9378595

COc1ccccc1C1CC=NN1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.46
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
USP2 O75604 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TACR1 P25103 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2B P41595 1/20 0.40
ADRA1A P35348 2/20 0.39
ADRA1D P25100 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA4 P22748 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9378077 0.77 HTR2C (0.42) HTR2CHTR2AHTR2BCA1CA2
SCHEMBL31392185 0.74 CA1 (0.44) HTR2CMEN1KMT2AHTR2BADRA1A
SCHEMBL5997174 0.72 MEN1 (0.44) HTR2CMEN1KMT2AUSP2L3MBTL1
SCHEMBL2666926 0.71 MAOA (0.44) HTR2CMEN1KMT2AUSP2L3MBTL1
SCHEMBL15959652 0.69 GRIN2B (0.49) HTR2CMEN1KMT2AUSP2L3MBTL1
SCHEMBL27385857 0.69 HTR2C (0.52) HTR2CMEN1KMT2AUSP2L3MBTL1
SCHEMBL1178805 0.69 MEN1 (0.38) MEN1KMT2AKDM4EMAPTGAA
SCHEMBL2666928 0.68 HTR2C (0.41) HTR2CMEN1KMT2AUSP2L3MBTL1
SCHEMBL23323077 0.68 MEN1 (0.65) HTR2CMEN1KMT2ATACR1
SCHEMBL469013 0.68 MEN1 (0.65) HTR2CMEN1KMT2ATACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0295695-B1 Pyrazoline derivatives and agents for treating cerebrovascular diseases containing the same as active ingredient MITSUI TOATSU CHEMICALS (JP) 1994-06-08 EP claimed
EP-0295695-B1 Pyrazoline derivatives and agents for treating cerebrovascular diseases containing the same as active ingredient MITSUI TOATSU CHEMICALS (JP) 1994-06-08 EP disclosed
US-4990529-A Nervous system disorder MITSUI TOATSU CHEMICALS (JP) 1991-02-05 US disclosed
US-4839376-A Pyrazoline derivatives for treating cerebrovascular diseases MITSUI TOATSU CHEMICALS, INC. (JP) 1989-06-13 US disclosed
EP-0295695-A2 Pyrazoline derivatives and agents for treating cerebrovascular diseases containing the same as active ingredient MITSUI TOATSU CHEMICALS, Inc. (JP) 1988-12-21 EP disclosed